Generating EngTregs to Overcome Key Challenges Associated with the Successful Application of Treg Cell Therapeutics

Time: 11:30 am
day: Day Two


  • Engineering abundant T cell populations with stabilized FOXP3 expression to create a scalable Treg Phenotype
  • Utilizing an inducible chimeric receptor to provide highly specific and tunable IL-2 signaling support
  • Providing tissue specificity and enhanced regulatory functions through antigenspecific CARs or TCRs